I agree that this site is using cookies. You can find further informations here.
X
Krueger, Julie
145  results:
Search for persons X
?
1

Social Determinants of Health:

, In: Pediatric Rotations,
Swamy, Padma ; Krueger, Julie - p. 459-472 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Experiences of the Transgender and Gender Non-Conforming Co..:

Simon, Ashton ; Noland, Sarah ; Krueger, Julie.
Building Healthy Academic Communities Journal.  7 (2023)  1 - p. 62-70 , 2023
Link: https://doi.org/10.18061..
 
?
3

Barriers to Infant Preventive Care During the COVID-19 Pand..:

Weisz, Jessica ; Krueger, Julie ; Henriques, Jane...
Clinical Pediatrics.  61 (2021)  1 - p. 17-21 , 2021
Link: https://doi.org/10.1177/..
 
?
4

Emergency Department Use for Non-emergent Asthma-related Sy..:

Kotwal, Mansi ; Tran, Jennifer ; Kirby, Todd...
Journal of Allergy and Clinical Immunology.  143 (2019)  2 - p. AB223 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Design, synthesis and SAR of a series of 1,3,5-trisubstitut..:

Isaacs, Richard C.A. ; Newton, Christina L. ; Cutrona, Kellie J....
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  5 - p. 1536-1540 , 2011
Link: https://doi.org/10.1016/..
 
?
6

P3 optimization of functional potency, in vivo efficacy and..:

Isaacs, Richard C.A. ; Newton, Christina L. ; Cutrona, Kellie J....
Bioorganic & Medicinal Chemistry Letters.  21 (2011)  5 - p. 1532-1535 , 2011
Link: https://doi.org/10.1016/..
 
?
7

Activation of farnesoid X receptor prevents atherosclerotic..:

Hartman, Helen B. ; Gardell, Stephen J. ; Petucci, Chris J....
Journal of Lipid Research.  50 (2009)  6 - p. 1090-1100 , 2009
Link: https://doi.org/10.1194/..
 
?
8

Structure-based design of novel groups for use in the P1 po..:

Isaacs, Richard C.A. ; Solinsky, Mark G. ; Cutrona, Kellie J....
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  6 - p. 2062-2066 , 2008
Link: https://doi.org/10.1016/..
 
?
9

Discovery of potent, selective 4-fluoroproline-based thromb..:

Staas, Donnette D. ; Savage, Kelly L. ; Sherman, Vanessa L....
Bioorganic & Medicinal Chemistry.  14 (2006)  20 - p. 6900-6916 , 2006
Link: https://doi.org/10.1016/..
 
?
10

Cyclopropylamino Acid Amide as a Pharmacophoric Replacement..:

Wood, Michael R. ; Schirripa, Kathy M. ; Kim, June J....
Journal of Medicinal Chemistry.  49 (2006)  4 - p. 1231-1234 , 2006
Link: https://doi.org/10.1021/..
 
?
11

Structure-based design of novel groups for use in the P1 po..:

Isaacs, Richard C.A. ; Solinsky, Mark G. ; Cutrona, Kellie J....
Bioorganic & Medicinal Chemistry Letters.  16 (2006)  2 - p. 338-342 , 2006
Link: https://doi.org/10.1016/..
 
?
12

P2 pyridine N-oxide thrombin inhibitors: a novel peptidomim..:

Nantermet, Philippe G. ; Burgey, Christopher S. ; Robinson, Kyle A....
Bioorganic & Medicinal Chemistry Letters.  15 (2005)  11 - p. 2771-2775 , 2005
Link: https://doi.org/10.1016/..
 
?
13

9-Hydroxyazafluorenes and Their Use in Thrombin Inhibitors:

Stauffer, Kenneth J. ; Williams, Peter D. ; Selnick, Harold G....
Journal of Medicinal Chemistry.  48 (2005)  7 - p. 2282-2293 , 2005
Link: https://doi.org/10.1021/..
 
?
14

Development of an oxazolopyridine series of dual thrombin/f..:

Deng, James Z. ; McMasters, Daniel R. ; Rabbat, Philippe M.A....
Bioorganic & Medicinal Chemistry Letters.  15 (2005)  20 - p. 4411-4416 , 2005
Link: https://doi.org/10.1016/..
 
?
15

Dissecting the Effects of DNA Polymerase and Ribonuclease H..:

Shaw-Reid, Cathryn A. ; Feuston, Bradley ; Munshi, Vandna...
Biochemistry.  44 (2005)  5 - p. 1595-1606 , 2005
Link: https://doi.org/10.1021/..
 
1-15